Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata

Enrolling by invitation

Conditions studied: Vitiligo, Psoriasis, Alopecia Areata, Atopic Dermatitis

In brief

It is a study of translational research with mechanistically objectives and including biological samples of patients with chronic inflammatory disorders

Key facts

Study ID

NCT03976622

Run by

University Hospital, Bordeaux

People needed

450

Starts

2020-01-14

Expected to finish

2027-06-03

Last updated by the study team

2026-06-18

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged 18 to 75 years;
• Patients with non-segmental vitiligo;
• Patients with plaque psoriasis;
• Patients with atopic dermatitis;
• Patients with alopecia areata sclerosis;
• written consent, free, informed and signed by the patient and the investigator (before any examination required by the study);
• Subject affiliated or beneficiary of a social security system.

You may not qualify if…

• Patients with segmental vitiligo
• Patients under local treatment (topical corticosteroid-Calcineurin inhibitor) for less than two weeks.
• Patients on therapy, systemic treatments: acitretin, methotrexate, cyclosporine, Apremilast, infliximab, adalimumab, etanercept, ustekinumab, secukinumab, ixekizumab, dupilumab) for less than 4 weeks.
• Pregnant or breastfeeding women
• Patient (e) under guardianship
• Patient (e) Non-affiliated (e) a social protection

Where it is running

• Service de Dermatologie - Hôpital Saint-André — Bordeaux, Bordeaux, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.